Expenditure on scientific research
(1)
A deduction shall be allowed for any expenditure, being in the nature of––
(2)
(a)
A deduction shall be allowed under sub-section (1) in respect of the aggregate of expenditure (not being in the nature of capital expenditure), related to business, incurred on—
(b)
For the purposes of sub-section (1), the aggregate of capital expenditure incurred within three years immediately preceding the commencement of business shall be deemed to have been incurred in the tax year in which the business is commenced.
(c)
(i)
A deduction shall be allowed under sub-section (1), in respect of any expenditure incurred (not being expenditure in the nature of cost of any land or building) by a company engaged in the business of—
(ii)
No deduction shall be allowed under this clause to a company approved under sub-section (3)(b)(ii);
(iii)
No deduction shall be allowed in respect of the expenditure mentioned in sub-clause (i) under any other provision of this Act;
(iv)
The expenditure under sub-clause (i) shall be allowed subject to such conditions and on furnishing of documents in such form and manner, as prescribed;
(d)
For the purposes of clause (c), expenditure on “scientific research”, in relation to drugs and pharmaceuticals, shall include expenditure incurred on clinical drug trial, 20 obtaining approval from any regulatory authority under any Central Act or State Act or Provincial Act and filing an application for a patent under the Patents Act, 1970.
(3)
A deduction shall be allowed for any sum, paid to—
(b)
a company which is––
(4)
For the purposes of sub-section (3),––
(5)
The deduction for any sum under sub-section (3) shall not be denied merely on the ground that subsequent to the payment of such sum by the assessee, the approval granted to such entities or the programme undertaken by entities as mentioned in sub-section(3)(c), has been withdrawn.
(6)
Where a deduction is allowed for any tax year under this section in respect of expenditure, represented wholly or partly by an asset, no deduction shall be allowed under section 33section 33(3) for the same or any other tax year in respect of that asset.
(7)
The provisions of section 33section 33(11) in respect of depreciation shall apply in relation to deductions allowable for capital expenditure under sub-section (1).
(8)
No deduction in respect of the sum mentioned in sub-section (3)(c) shall be allowed under any other provision of this Act.
(9)
If any question arises under this section as to whether, and if so, to what extent any activity constitutes or constituted scientific research, or any asset is or was being used, for scientific research, the Board shall refer the question to—
(b)
the prescribed authority, when such question relates to any other activity, whose decision shall be final.
(10)
When an amalgamating company, in a scheme of amalgamation, sells or otherwise transfers to the amalgamated company (being an Indian company) any asset representing capital expenditure on scientific research, the provisions of this section shall apply to the amalgamated company as they would have applied to the amalgamating company if the latter had not so sold or otherwise transferred the asset.
(11)
In this section,—
(a)
“National Laboratory” means a scientific laboratory functioning at the national level under the aegis of the Indian Council of Agricultural Research, the Indian Council of Medical Research, the Council of Scientific and Industrial Research, the Defence Research and Development Organisation, the Department of Electronics, the Department of Bio-Technology or the Department of Atomic Energy and which is approved as a National Laboratory by such authority and in such manner, as prescribed;
(b)
“specified person” means such person approved by the prescribed authority;
(c)
“land” includes any interest in land.